Anti-Chlamydia trachomatis antibody (FITC) (ab20723)

Overview

  • Product nameAnti-Chlamydia trachomatis antibody (FITC)
    See all Chlamydia trachomatis primary antibodies
  • Description
    Goat polyclonal to Chlamydia trachomatis (FITC)
  • ConjugationFITC. Ex: 493nm, Em: 528nm
  • SpecificityPurified elementary bodies, disrupted. Cross-reacts with Chlamydia psittacii & Chlamydia pneumoniae (TWAR). Negative vs. HEp2 cells and egg yolk sac. All antigens of strain L2.
  • Tested applicationsSuitable for: ICC/IFmore details
  • Species reactivity
    Reacts with: Chlamydia trachomatis
  • Immunogen

    L2 and other serovar groups.

  • General notes

    Covalently coupled with high purity Isomer I of fluorescein isothiocyanate.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at +4°C.
  • Storage bufferPreservative: 0.1% Sodium Azide
    Constituents: 10mg/ml BSA, 0.01M PBS, pH 7.2
  • Concentration information loading...
  • PurityIgG fraction
  • Purification notesCare is taken to ensure complete removal of any free fluorescein from the final product.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab20723 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ICC/IF
  • Application notesIF: 1/10 - 1/50. Acetone fixation of the antigen source is recommended prior to staining.

    Not tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • RelevanceChlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5% to 10%. Chlamydia is one of the leading causes of blindness in underdeveloped countries.
    • Database links
      • Alternative names
        • C.trachomatis antibody

      References for Anti-Chlamydia trachomatis antibody (FITC) (ab20723)

      ab20723 has not yet been referenced specifically in any publications.

      Product Wall

      There are currently no Abreviews or Questions for ab20723.
      Please use the links above to contact us or submit feedback about this product.

      Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"